2011
DOI: 10.1038/cgt.2011.55
|View full text |Cite
|
Sign up to set email alerts
|

SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer

Abstract: Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human ovarian cancers and its overexpression is associated with increased angiogenesis, increased metastasis and reduced survival. Inhibition of HER2 in HER2-overexpressing cancers can lead to reduced angiogenesis and improved survival. Previously, we reported that SV40 T/t-common polypeptide has transcriptional repression activity and can inhibit HER2 expression. In this study, we investigated the effect of T/t-common on the angiog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2013
2013

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…RNA extraction and quantitative reverse transcription-PCR (RT-PCR) were performed as described previously (59). cDNA was synthesized using 1 g of total RNA as the template and oligo(dT) 18 (for NP mRNA), 5=-CTCATCCTTTATGA CAAAGAAG-3= (for NP vRNA), or 5=-AGTAGAAACAAGGGTATTTTT CTTT-3= (for NP cRNA) as the primer according to the manufacturer's protocol for reverse transcription (Invitrogen).…”
Section: Methodsmentioning
confidence: 99%
“…RNA extraction and quantitative reverse transcription-PCR (RT-PCR) were performed as described previously (59). cDNA was synthesized using 1 g of total RNA as the template and oligo(dT) 18 (for NP mRNA), 5=-CTCATCCTTTATGA CAAAGAAG-3= (for NP vRNA), or 5=-AGTAGAAACAAGGGTATTTTT CTTT-3= (for NP cRNA) as the primer according to the manufacturer's protocol for reverse transcription (Invitrogen).…”
Section: Methodsmentioning
confidence: 99%